Immunome (IMNM) Operating Income Growth (1y) (2020 - 2026)
Immunome (IMNM) Operating Income Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,930.48 Bn | 1,930.42 Bn | - | - |
| 3 | Akari Therapeutics | 1,071.19 Bn | 1,071.19 Bn | - | - |
| 4 | BeOne Medicines | 468.55 Bn | 463.76 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 123.04 Bn | 115.79 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 70.31 Bn | 61.56 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 63.40 Bn | 63.40 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | 145.20% |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn | 1,386.07% |
| 10 | Immunome | 2.58 Bn | 2.00 Bn | - | -32.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.92% |
| Dec 31, 2025 | 12.18% |
| Sep 30, 2025 | -19.03% |
| Jun 30, 2025 | -16.17% |
| Mar 31, 2025 | 66.26% |
| Dec 31, 2024 | 12.34% |
| Sep 30, 2024 | -990.48% |
| Jun 30, 2024 | -593.04% |
| Mar 31, 2024 | -2,859.05% |
| Dec 31, 2023 | -1,115.53% |
| Sep 30, 2023 | 45.71% |
| Jun 30, 2023 | 35.32% |
| Mar 31, 2023 | 61.64% |
| Dec 31, 2022 | 0.73% |
| Sep 30, 2022 | -10.50% |
| Jun 30, 2022 | -55.51% |
| Mar 31, 2022 | -199.05% |
| Dec 31, 2021 | -92.59% |
| Sep 30, 2021 | -174.06% |
| Jun 30, 2021 | -111.42% |